{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:31:35Z","timestamp":1789536695778,"version":"build-2803163510"},"reference-count":275,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03165-3","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T17:03:53Z","timestamp":1759165433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effects of exercise on neuroinflammation in age-related neurodegenerative disorders"],"prefix":"10.1186","volume":"30","author":[{"given":"Yiping","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanguo","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"issue":"5","key":"3165_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, et al. Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459\u201380.","journal-title":"Lancet Neurol"},{"key":"3165_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-020-0117-1","volume":"6","author":"W Yang","year":"2020","unstructured":"Yang W, et al. Current and projected future economic burden of Parkinson\u2019s disease in the U.S. NPJ Parkinsons Dis. 2020;6:15.","journal-title":"NPJ Parkinsons Dis"},{"key":"3165_CR3","unstructured":"who\/news-room\/fact-sheets\/detail\/physical-activity. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/physical-activity."},{"key":"3165_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2019.02338","volume":"10","author":"F Herold","year":"2019","unstructured":"Herold F, et al. Dose-response matters! - a perspective on the exercise prescription in exercise-cognition research. Front Psychol. 2019;10:2338.","journal-title":"Front Psychol"},{"key":"3165_CR5","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a029694","author":"GN Ruegsegger","year":"2018","unstructured":"Ruegsegger GN, Booth FW. Health benefits of exercise. Cold Spring Harb Perspect Med. 2018. https:\/\/doi.org\/10.1101\/cshperspect.a029694.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"3165_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.14283\/jpad.2022.9","volume":"9","author":"V Alanko","year":"2022","unstructured":"Alanko V, et al. Mechanisms underlying non-pharmacological dementia prevention strategies: a translational perspective. J Prev Alzheimers Dis. 2022;9(1):3\u201311.","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"3165_CR7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41380-022-01819-w","volume":"28","author":"RE Ross","year":"2023","unstructured":"Ross RE, et al. The role of exercise in the treatment of depression: biological underpinnings and clinical outcomes. Mol Psychiatry. 2023;28(1):298\u2013328.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"3165_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1615\/CritRevEukaryotGeneExpr.2016015920","volume":"26","author":"LS Silveira","year":"2016","unstructured":"Silveira LS, et al. Macrophage polarization: implications on metabolic diseases and the role of exercise. Crit Rev Eukaryot Gene Expr. 2016;26(2):115\u201332.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"9","key":"3165_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nri3041","volume":"11","author":"M Gleeson","year":"2011","unstructured":"Gleeson M, et al. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol. 2011;11(9):607\u201315.","journal-title":"Nat Rev Immunol"},{"key":"3165_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/bs.pmbts.2015.07.003","volume":"135","author":"J Allen","year":"2015","unstructured":"Allen J, Sun Y, Woods JA. Exercise and the regulation of inflammatory responses. Prog Mol Biol Transl Sci. 2015;135:337\u201354.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"11","key":"3165_CR11","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/intimm\/dxy054","volume":"30","author":"Y Oishi","year":"2018","unstructured":"Oishi Y, Manabe I. Macrophages in inflammation, repair and regeneration. Int Immunol. 2018;30(11):511\u201328.","journal-title":"Int Immunol"},{"issue":"6","key":"3165_CR12","first-page":"2633","volume":"31","author":"M Roca-Rodr\u00edguez Mdel","year":"2015","unstructured":"Roca-Rodr\u00edguez Mdel M, et al. Effects of exercise on inflammation in cardiac rehabilitation. Nutr Hosp. 2015;31(6):2633\u201340.","journal-title":"Nutr Hosp"},{"issue":"8","key":"3165_CR13","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/eci.12781","volume":"47","author":"BK Pedersen","year":"2017","unstructured":"Pedersen BK. Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease. Eur J Clin Invest. 2017;47(8):600\u201311.","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"3165_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2165\/00007256-200131020-00004","volume":"31","author":"AI Moldoveanu","year":"2001","unstructured":"Moldoveanu AI, Shephard RJ, Shek PN. The cytokine response to physical activity and training. Sports Med. 2001;31(2):115\u201344.","journal-title":"Sports Med"},{"issue":"4","key":"3165_CR15","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1152\/japplphysiol.00164.2004","volume":"98","author":"AM Petersen","year":"2005","unstructured":"Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol (1985). 2005;98(4):1154\u201362.","journal-title":"J Appl Physiol (1985)"},{"key":"3165_CR16","first-page":"8","volume":"14","author":"BW Timmons","year":"2008","unstructured":"Timmons BW, Cieslak T. Human natural killer cell subsets and acute exercise: a brief review. Exerc Immunol Rev. 2008;14:8\u201323.","journal-title":"Exerc Immunol Rev"},{"issue":"9","key":"3165_CR17","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1096\/fj.201700080R","volume":"31","author":"SR Hennigar","year":"2017","unstructured":"Hennigar SR, McClung JP, Pasiakos SM. Nutritional interventions and the IL-6 response to exercise. FASEB j. 2017;31(9):3719\u201328.","journal-title":"FASEB j"},{"issue":"5","key":"3165_CR18","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1152\/japplphysiol.00622.2016","volume":"122","author":"JM Peake","year":"2017","unstructured":"Peake JM, et al. Recovery of the immune system after exercise. J Appl Physiol (1985). 2017;122(5):1077\u201387.","journal-title":"J Appl Physiol (1985)"},{"issue":"107","key":"3165_CR19","first-page":"433","volume":"19","author":"AB Bigley","year":"2015","unstructured":"Bigley AB, Simpson RJ. NK cells and exercise: implications for cancer immunotherapy and survivorship. Discov Med. 2015;19(107):433\u201345.","journal-title":"Discov Med"},{"issue":"6","key":"3165_CR20","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/BOR.0000000000000337","volume":"28","author":"AP Lightfoot","year":"2016","unstructured":"Lightfoot AP, Cooper RG. The role of myokines in muscle health and disease. Curr Opin Rheumatol. 2016;28(6):661\u20136.","journal-title":"Curr Opin Rheumatol"},{"key":"3165_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cyto.2017.10.001","volume":"104","author":"DM Shaw","year":"2018","unstructured":"Shaw DM, et al. T-cells and their cytokine production: the anti-inflammatory and immunosuppressive effects of strenuous exercise. Cytokine. 2018;104:136\u201342.","journal-title":"Cytokine"},{"key":"3165_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.coi.2019.11.007","volume":"62","author":"S Christgen","year":"2020","unstructured":"Christgen S, Kanneganti TD. Inflammasomes and the fine line between defense and disease. Curr Opin Immunol. 2020;62:39\u201344.","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"3165_CR23","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.immuni.2024.03.014","volume":"57","author":"SL Carroll","year":"2024","unstructured":"Carroll SL, Pasare C, Barton GM. Control of adaptive immunity by pattern recognition receptors. Immunity. 2024;57(4):632\u201348.","journal-title":"Immunity"},{"issue":"1","key":"3165_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","volume":"6","author":"D Li","year":"2021","unstructured":"Li D, Wu M. Pattern recognition receptors in health and diseases. Signal Transduct Target Ther. 2021;6(1):291.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"3165_CR25","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/nrneph.2014.91","volume":"10","author":"JC Leemans","year":"2014","unstructured":"Leemans JC, et al. Pattern recognition receptors and the inflammasome in kidney disease. Nat Rev Nephrol. 2014;10(7):398\u2013414.","journal-title":"Nat Rev Nephrol"},{"key":"3165_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.coi.2013.11.003","volume":"26","author":"J Moretti","year":"2014","unstructured":"Moretti J, Blander JM. Insights into phagocytosis-coupled activation of pattern recognition receptors and inflammasomes. Curr Opin Immunol. 2014;26:100\u201310.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"3165_CR27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12974-024-03055-1","volume":"21","author":"A Brandli","year":"2024","unstructured":"Brandli A, Vessey KA, Fletcher EL. The contribution of pattern recognition receptor signalling in the development of age related macular degeneration: the role of toll-like-receptors and the NLRP3-inflammasome. J Neuroinflammation. 2024;21(1):64.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3165_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/imr.12839","volume":"294","author":"L Spel","year":"2020","unstructured":"Spel L, Martinon F. Inflammasomes contributing to inflammation in arthritis. Immunol Rev. 2020;294(1):48\u201362.","journal-title":"Immunol Rev"},{"issue":"7","key":"3165_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm.3893","volume":"21","author":"H Guo","year":"2015","unstructured":"Guo H, Callaway JB, Ting JP. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015;21(7):677\u201387.","journal-title":"Nat Med"},{"key":"3165_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc7409","author":"JM Navarro-Pando","year":"2021","unstructured":"Navarro-Pando JM, et al. Inhibition of the NLRP3 inflammasome prevents ovarian aging. Sci Adv. 2021. https:\/\/doi.org\/10.1126\/sciadv.abc7409.","journal-title":"Sci Adv"},{"issue":"1","key":"3165_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13050","volume":"19","author":"F Mar\u00edn-Aguilar","year":"2020","unstructured":"Mar\u00edn-Aguilar F, et al. NLRP3 inflammasome suppression improves longevity and prevents cardiac aging in male mice. Aging Cell. 2020;19(1):e13050.","journal-title":"Aging Cell"},{"issue":"4","key":"3165_CR32","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.cmet.2013.09.010","volume":"18","author":"YH Youm","year":"2013","unstructured":"Youm YH, et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab. 2013;18(4):519\u201332.","journal-title":"Cell Metab"},{"issue":"1","key":"3165_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tem.2017.10.009","volume":"29","author":"MD Cordero","year":"2018","unstructured":"Cordero MD, Williams MR, Ryffel B. AMP-activated protein kinase regulation of the NLRP3 inflammasome during aging. Trends Endocrinol Metab. 2018;29(1):8\u201317.","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"3165_CR34","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.immuni.2019.03.016","volume":"50","author":"TR Hammond","year":"2019","unstructured":"Hammond TR, Marsh SE, Stevens B. Immune signaling in neurodegeneration. Immunity. 2019;50(4):955\u201374.","journal-title":"Immunity"},{"issue":"11","key":"3165_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112903","volume":"10","author":"RM Parodi-Rull\u00e1n","year":"2021","unstructured":"Parodi-Rull\u00e1n RM, Javadov S, Fossati S. Dissecting the crosstalk between endothelial mitochondrial damage, vascular inflammation, and neurodegeneration in cerebral amyloid angiopathy and Alzheimer\u2019s disease. Cells. 2021;10(11):2903.","journal-title":"Cells"},{"issue":"7973","key":"3165_CR36","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","volume":"620","author":"MF Gulen","year":"2023","unstructured":"Gulen MF, et al. cGAS\u2013STING drives ageing-related inflammation and neurodegeneration. Nature. 2023;620(7973):374\u201380.","journal-title":"Nature"},{"issue":"6286","key":"3165_CR37","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352(6286):712\u20136.","journal-title":"Science"},{"issue":"1","key":"3165_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-018-0244-x","volume":"13","author":"J Sosna","year":"2018","unstructured":"Sosna J, et al. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer\u2019s disease. Mol Neurodegener. 2018;13(1):11.","journal-title":"Mol Neurodegener"},{"key":"3165_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf6295","author":"Q Shi","year":"2017","unstructured":"Shi Q, et al. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice. Sci Transl Med. 2017. https:\/\/doi.org\/10.1126\/scitranslmed.aaf6295.","journal-title":"Sci Transl Med"},{"issue":"11","key":"3165_CR40","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/nn1997","volume":"10","author":"UK Hanisch","year":"2007","unstructured":"Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007;10(11):1387\u201394.","journal-title":"Nat Neurosci"},{"issue":"1","key":"3165_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15267-z","volume":"11","author":"LP Bernier","year":"2020","unstructured":"Bernier LP, et al. Microglial metabolic flexibility supports immune surveillance of the brain parenchyma. Nat Commun. 2020;11(1):1559.","journal-title":"Nat Commun"},{"key":"3165_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22157781","author":"F Bright","year":"2021","unstructured":"Bright F, et al. TDP-43 and inflammation: implications for amyotrophic lateral sclerosis and frontotemporal dementia. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22157781.","journal-title":"Int J Mol Sci"},{"key":"3165_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.796288","volume":"13","author":"Y Mou","year":"2022","unstructured":"Mou Y, et al. Gut microbiota interact with the brain through systemic chronic inflammation: implications on neuroinflammation, neurodegeneration, and aging. Front Immunol. 2022;13:796288.","journal-title":"Front Immunol"},{"issue":"12","key":"3165_CR44","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/s12276-021-00703-x","volume":"53","author":"J Park","year":"2021","unstructured":"Park J, Kim CH. Regulation of common neurological disorders by gut microbial metabolites. Exp Mol Med. 2021;53(12):1821\u201333.","journal-title":"Exp Mol Med"},{"issue":"3","key":"3165_CR45","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3233\/JAD-220205","volume":"88","author":"A Fairley","year":"2022","unstructured":"Fairley A, et al. Diet patterns, the gut microbiome, and Alzheimer\u2019s disease. J Alzheimers Dis. 2022;88(3):933\u201341.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"3165_CR46","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/glia.24175","volume":"70","author":"X Zheng","year":"2022","unstructured":"Zheng X, et al. Progranulin deficiency promotes persistent neuroinflammation and causes regional pathology in the hippocampus following traumatic brain injury. Glia. 2022;70(7):1317\u201336.","journal-title":"Glia"},{"issue":"1","key":"3165_CR47","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/MOL.0000000000000801","volume":"33","author":"MV Duro","year":"2022","unstructured":"Duro MV, Ebright B, Yassine HN. Lipids and brain inflammation in APOE4-associated dementia. Curr Opin Lipidol. 2022;33(1):16\u201324.","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"3165_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/embj.201386609","volume":"33","author":"M Schwartz","year":"2014","unstructured":"Schwartz M, Baruch K. The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. EMBO J. 2014;33(1):7\u201322.","journal-title":"EMBO J"},{"issue":"3","key":"3165_CR49","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/alz.12068","volume":"16","author":"L Zhao","year":"2020","unstructured":"Zhao L. Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2020;16(3):391\u2013460.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"3165_CR50","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s41232-020-00137-4","volume":"40","author":"K Otani","year":"2020","unstructured":"Otani K, Shichita T. Cerebral sterile inflammation in neurodegenerative diseases. Inflamm Regen. 2020;40(1):28.","journal-title":"Inflamm Regen"},{"issue":"4","key":"3165_CR51","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, et al. Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol. 2013;12(4):357\u201367.","journal-title":"Lancet Neurol"},{"issue":"10","key":"3165_CR52","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/WNL.0b013e3182840bbe","volume":"80","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, et al. Brain \u03b2-amyloid load approaches a plateau. Neurology. 2013;80(10):890\u20136.","journal-title":"Neurology"},{"issue":"3","key":"3165_CR53","first-page":"748","volume":"140","author":"MJ Pontecorvo","year":"2017","unstructured":"Pontecorvo MJ, et al. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Brain. 2017;140(3):748\u201363.","journal-title":"Brain"},{"issue":"7","key":"3165_CR54","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014;14(7):463\u201377.","journal-title":"Nat Rev Immunol"},{"key":"3165_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114291","volume":"235","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, et al. Toll-like receptor 4 (TLR4) inhibitors: current research and prospective. Eur J Med Chem. 2022;235:114291.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"3165_CR56","first-page":"7924199","volume":"2022","author":"L Wu","year":"2022","unstructured":"Wu L, et al. Toll-like receptor 4: a promising therapeutic target for Alzheimer\u2019s disease. Mediat Inflamm. 2022;2022(1):7924199.","journal-title":"Mediat Inflamm"},{"key":"3165_CR57","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1007\/s11033-020-06130-x","volume":"48","author":"T Behl","year":"2021","unstructured":"Behl T, et al. Expatiating the molecular approaches of HMGB1 in diabetes mellitus: highlighting signalling pathways via RAGE and TLRs. Mol Biol Rep. 2021;48:1869\u201381.","journal-title":"Mol Biol Rep"},{"issue":"4","key":"3165_CR58","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.neuron.2020.08.012","volume":"108","author":"M Linnerbauer","year":"2020","unstructured":"Linnerbauer M, Wheeler MA, Quintana FJ. Astrocyte crosstalk in CNS inflammation. Neuron. 2020;108(4):608\u201322.","journal-title":"Neuron"},{"key":"3165_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9050524","author":"IG Onyango","year":"2021","unstructured":"Onyango IG, et al. Neuroinflammation in Alzheimer\u2019s disease. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9050524.","journal-title":"Biomedicines"},{"issue":"2","key":"3165_CR60","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer\u2019s disease. J Cell Biol. 2018;217(2):459\u201372.","journal-title":"J Cell Biol"},{"key":"3165_CR61","doi-asserted-by":"publisher","first-page":"6039171","DOI":"10.1155\/2018\/6039171","volume":"2018","author":"E Costantini","year":"2018","unstructured":"Costantini E, D\u2019Angelo C, Reale M. The role of immunosenescence in neurodegenerative diseases. Mediat Inflamm. 2018;2018:6039171.","journal-title":"Mediat Inflamm"},{"issue":"6","key":"3165_CR62","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0197-4580(01)00307-4","volume":"22","author":"L Meda","year":"2001","unstructured":"Meda L, Baron P, Scarlato G. Glial activation in Alzheimer\u2019s disease: the role of Abeta and its associated proteins. Neurobiol Aging. 2001;22(6):885\u201393.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"3165_CR63","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/alzrt29","volume":"2","author":"ZS Tan","year":"2010","unstructured":"Tan ZS, Seshadri S. Inflammation in the Alzheimer\u2019s disease cascade: culprit or innocent bystander? Alzheimers Res Ther. 2010;2(2):6.","journal-title":"Alzheimers Res Ther"},{"issue":"7831","key":"3165_CR64","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41586-020-2681-2","volume":"586","author":"JY Hur","year":"2020","unstructured":"Hur JY, et al. The innate immunity protein IFITM3 modulates \u03b3-secretase in Alzheimer\u2019s disease. Nature. 2020;586(7831):735\u201340.","journal-title":"Nature"},{"issue":"2","key":"3165_CR65","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00401-014-1371-2","volume":"129","author":"RM Nisbet","year":"2015","unstructured":"Nisbet RM, et al. Tau aggregation and its interplay with amyloid-\u03b2. Acta Neuropathol. 2015;129(2):207\u201320.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"3165_CR66","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama Y, et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron. 2007;53(3):337\u201351.","journal-title":"Neuron"},{"issue":"Pt 6","key":"3165_CR67","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/brain\/awv081","volume":"138","author":"N Maphis","year":"2015","unstructured":"Maphis N, et al. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. Brain. 2015;138(Pt 6):1738\u201355.","journal-title":"Brain"},{"issue":"1","key":"3165_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1313-3","volume":"15","author":"EA Newcombe","year":"2018","unstructured":"Newcombe EA, et al. Inflammation: the link between comorbidities, genetics, and Alzheimer\u2019s disease. J Neuroinflammation. 2018;15(1):276.","journal-title":"J Neuroinflammation"},{"issue":"5","key":"3165_CR69","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","volume":"133","author":"T Guo","year":"2017","unstructured":"Guo T, Noble W, Hanger DP. Roles of tau protein in health and disease. Acta Neuropathol. 2017;133(5):665\u2013704.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"3165_CR70","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, et al. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918\u201334.","journal-title":"Cell"},{"key":"3165_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01005","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu J, Wang F. Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications. Front Immunol. 2017;8:1005.","journal-title":"Front Immunol"},{"issue":"5796","key":"3165_CR72","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130\u20133.","journal-title":"Science"},{"key":"3165_CR73","first-page":"181","volume":"7","author":"C Ingre","year":"2015","unstructured":"Ingre C, et al. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181\u201393.","journal-title":"Clin Epidemiol"},{"issue":"9","key":"3165_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12091747","volume":"12","author":"V Rubino","year":"2023","unstructured":"Rubino V, et al. Insights on the multifaceted roles of wild-type and mutated superoxide dismutase 1 in amyotrophic lateral sclerosis pathogenesis. Antioxidants. 2023;12(9):1747.","journal-title":"Antioxidants"},{"key":"3165_CR75","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2021.11.031","volume":"178","author":"L Xiong","year":"2022","unstructured":"Xiong L, et al. Inflammation-dependent oxidative stress metabolites as a hallmark of amyotrophic lateral sclerosis. Free Radic Biol Med. 2022;178:125\u201333.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"3165_CR76","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.cell.2020.09.020","volume":"183","author":"CH Yu","year":"2020","unstructured":"Yu CH, et al. TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS\/STING in ALS. Cell. 2020;183(3):636\u201349.","journal-title":"Cell"},{"key":"3165_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00679","volume":"14","author":"ML Cali\u00f3","year":"2020","unstructured":"Cali\u00f3 ML, et al. Mitochondrial dysfunction, neurogenesis, and epigenetics: putative implications for amyotrophic lateral sclerosis neurodegeneration and treatment. Front Neurosci. 2020;14:679.","journal-title":"Front Neurosci"},{"issue":"4","key":"3165_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11040614","volume":"11","author":"C Peggion","year":"2022","unstructured":"Peggion C, et al. SOD1 in ALS: taking stock in pathogenic mechanisms and the role of glial and muscle cells. Antioxidants. 2022;11(4):614.","journal-title":"Antioxidants"},{"key":"3165_CR79","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.expneurol.2015.07.019","volume":"273","author":"W Zhao","year":"2015","unstructured":"Zhao W, et al. TDP-43 activates microglia through NF-\u03baB and NLRP3 inflammasome. Exp Neurol. 2015;273:24\u201335.","journal-title":"Exp Neurol"},{"issue":"1","key":"3165_CR80","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nn1603","volume":"9","author":"M Urushitani","year":"2006","unstructured":"Urushitani M, et al. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci. 2006;9(1):108\u201318.","journal-title":"Nat Neurosci"},{"issue":"7","key":"3165_CR81","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1007\/s12035-023-03289-9","volume":"60","author":"J Kaur","year":"2023","unstructured":"Kaur J, Singh H, Naqvi S. Intracellular DAMPs in neurodegeneration and their role in clinical therapeutics. Mol Neurobiol. 2023;60(7):3600\u201316.","journal-title":"Mol Neurobiol"},{"key":"3165_CR82","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa124","author":"LC B\u00e9land","year":"2020","unstructured":"B\u00e9land LC, et al. Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses. Brain Commun. 2020. https:\/\/doi.org\/10.1093\/braincomms\/fcaa124.","journal-title":"Brain Commun"},{"issue":"14","key":"3165_CR83","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1212\/WNL.0b013e3182a6cc13","volume":"81","author":"MR Turner","year":"2013","unstructured":"Turner MR, et al. Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology. 2013;81(14):1222\u20135.","journal-title":"Neurology"},{"issue":"1","key":"3165_CR84","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12916-021-01903-y","volume":"19","author":"CY Li","year":"2021","unstructured":"Li CY, et al. Genome-wide genetic links between amyotrophic lateral sclerosis and autoimmune diseases. BMC Med. 2021;19(1):27.","journal-title":"BMC Med"},{"issue":"11","key":"3165_CR85","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, et al. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22(11):657\u201373.","journal-title":"Nat Rev Immunol"},{"issue":"Pt 8","key":"3165_CR86","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower JH, et al. Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease. Brain. 2013;136(Pt 8):2419\u201331.","journal-title":"Brain"},{"key":"3165_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.580311","volume":"14","author":"V Gundersen","year":"2020","unstructured":"Gundersen V. Parkinson\u2019s disease: can targeting inflammation be an effective neuroprotective strategy? Front Neurosci. 2020;14:580311.","journal-title":"Front Neurosci"},{"issue":"8","key":"3165_CR88","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, et al. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology. 1988;38(8):1285\u201391.","journal-title":"Neurology"},{"issue":"24","key":"3165_CR89","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1212\/WNL.0b013e318278fe32","volume":"79","author":"JM Milber","year":"2012","unstructured":"Milber JM, et al. Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease. Neurology. 2012;79(24):2307\u201314.","journal-title":"Neurology"},{"issue":"6109","key":"3165_CR90","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, et al. Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012;338(6109):949\u201353.","journal-title":"Science"},{"issue":"4","key":"3165_CR91","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04240-2","volume":"79","author":"GK Tofaris","year":"2022","unstructured":"Tofaris GK. Initiation and progression of \u03b1-synuclein pathology in Parkinson\u2019s disease. Cell Mol Life Sci. 2022;79(4):210.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"3165_CR92","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/bph.15684","volume":"179","author":"ME Haque","year":"2022","unstructured":"Haque ME, et al. Targeting \u03b1-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson\u2019s disease. Br J Pharmacol. 2022;179(1):23\u201345.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"3165_CR93","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang W, et al. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease. Faseb J. 2005;19(6):533\u201342.","journal-title":"Faseb J"},{"key":"3165_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/cells8080776","author":"L Acu\u00f1a","year":"2019","unstructured":"Acu\u00f1a L, et al. Rifampicin and its derivative rifampicin quinone reduce microglial inflammatory responses and neurodegeneration induced in vitro by \u03b1-synuclein fibrillary aggregates. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8080776.","journal-title":"Cells"},{"issue":"1","key":"3165_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04422-2","volume":"9","author":"MHR Ludtmann","year":"2018","unstructured":"Ludtmann MHR, et al. \u0391-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson\u2019s disease. Nat Commun. 2018;9(1):2293.","journal-title":"Nat Commun"},{"key":"3165_CR96","doi-asserted-by":"crossref","unstructured":"Di Maio, R., et al., \u03b1-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease. Sci Transl Med, 2016. 8(342): p. 342ra78.","DOI":"10.1126\/scitranslmed.aaf3634"},{"issue":"1","key":"3165_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1171-z","volume":"15","author":"MF Duffy","year":"2018","unstructured":"Duffy MF, et al. Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration. J Neuroinflammation. 2018;15(1):129.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3165_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11928-w","volume":"10","author":"P Krashia","year":"2019","unstructured":"Krashia P, et al. Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson\u2019s disease. Nat Commun. 2019;10(1):3945.","journal-title":"Nat Commun"},{"issue":"1","key":"3165_CR99","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4103\/1673-5374.343895","volume":"18","author":"A Cardinale","year":"2023","unstructured":"Cardinale A, Calabrese V. The intricate debate on neurodegeneration and neuroinflammation in Parkinson\u2019s disease: which came first? Neural Regen Res. 2023;18(1):125\u20136.","journal-title":"Neural Regen Res"},{"key":"3165_CR100","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/ncomms2534","volume":"4","author":"C Kim","year":"2013","unstructured":"Kim C, et al. Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun. 2013;4:1562.","journal-title":"Nat Commun"},{"issue":"1","key":"3165_CR101","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","volume":"11","author":"I Choi","year":"2020","unstructured":"Choi I, et al. Microglia clear neuron-released \u03b1-synuclein via selective autophagy and prevent neurodegeneration. Nat Commun. 2020;11(1):1386.","journal-title":"Nat Commun"},{"issue":"4","key":"3165_CR102","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ana.25557","volume":"86","author":"V Grozdanov","year":"2019","unstructured":"Grozdanov V, et al. Increased immune activation by pathologic \u03b1-synuclein in Parkinson\u2019s disease. Ann Neurol. 2019;86(4):593\u2013606.","journal-title":"Ann Neurol"},{"key":"3165_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/biom12050655","author":"C Chavarr\u00eda","year":"2022","unstructured":"Chavarr\u00eda C, Ivagnes R, Souza JM. Extracellular alpha-synuclein: mechanisms for glial cell internalization and activation. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12050655.","journal-title":"Biomolecules"},{"key":"3165_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071687","author":"M Pajares","year":"2020","unstructured":"Pajares M, et al. Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9071687.","journal-title":"Cells"},{"key":"3165_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116216","author":"I Kawahata","year":"2022","unstructured":"Kawahata I, Finkelstein DI, Fukunaga K. Pathogenic impact of \u03b1-synuclein phosphorylation and its kinases in \u03b1-synucleinopathies. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23116216.","journal-title":"Int J Mol Sci"},{"key":"3165_CR106","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.nbd.2018.03.001","volume":"115","author":"L Reimer","year":"2018","unstructured":"Reimer L, et al. Inflammation kinase PKR phosphorylates \u03b1-synuclein and causes \u03b1-synuclein-dependent cell death. Neurobiol Dis. 2018;115:17\u201328.","journal-title":"Neurobiol Dis"},{"issue":"15","key":"3165_CR107","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109617119","volume":"119","author":"SS Ghanem","year":"2022","unstructured":"Ghanem SS, et al. \u03b1-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity. Proc Natl Acad Sci U S A. 2022;119(15):e2109617119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3165_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105654","volume":"166","author":"A Kasen","year":"2022","unstructured":"Kasen A, et al. Upregulation of \u03b1-synuclein following immune activation: possible trigger of Parkinson\u2019s disease. Neurobiol Dis. 2022;166:105654.","journal-title":"Neurobiol Dis"},{"issue":"7","key":"3165_CR109","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1093\/brain\/awab122","volume":"144","author":"Y Xia","year":"2021","unstructured":"Xia Y, et al. Reactive microglia enhance the transmission of exosomal \u03b1-synuclein via toll-like receptor 2. Brain. 2021;144(7):2024\u201337.","journal-title":"Brain"},{"issue":"6","key":"3165_CR110","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1093\/brain\/awz104","volume":"142","author":"CW Olanow","year":"2019","unstructured":"Olanow CW, et al. Temporal evolution of microglia and \u03b1-synuclein accumulation following foetal grafting in Parkinson\u2019s disease. Brain. 2019;142(6):1690\u2013700.","journal-title":"Brain"},{"key":"3165_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.09.007","author":"H Scheiblich","year":"2021","unstructured":"Scheiblich H, et al. Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes. Cell. 2021. https:\/\/doi.org\/10.1016\/j.cell.2021.09.007.","journal-title":"Cell"},{"issue":"1","key":"3165_CR112","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12974-021-02158-3","volume":"18","author":"J Rostami","year":"2021","unstructured":"Rostami J, et al. Crosstalk between astrocytes and microglia results in increased degradation of \u03b1-synuclein and amyloid-\u03b2 aggregates. J Neuroinflammation. 2021;18(1):124.","journal-title":"J Neuroinflammation"},{"issue":"7660","key":"3165_CR113","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer D, et al. T cells from patients with Parkinson\u2019s disease recognize \u03b1-synuclein peptides. Nature. 2017;546(7660):656\u201361.","journal-title":"Nature"},{"issue":"1","key":"3165_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15626-w","volume":"11","author":"CS Lindestam Arlehamn","year":"2020","unstructured":"Lindestam Arlehamn CS, et al. \u0391-synuclein-specific T cell reactivity is associated with preclinical and early Parkinson\u2019s disease. Nat Commun. 2020;11(1):1875.","journal-title":"Nat Commun"},{"key":"3165_CR115","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2022.01.007","volume":"101","author":"AA Karikari","year":"2022","unstructured":"Karikari AA, et al. Neurodegeneration by \u03b1-synuclein-specific T cells in AAV-A53T-\u03b1-synuclein Parkinson\u2019s disease mice. Brain Behav Immun. 2022;101:194\u2013210.","journal-title":"Brain Behav Immun"},{"issue":"7","key":"3165_CR116","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1474-4422(22)00121-1","volume":"21","author":"SJ Tabrizi","year":"2022","unstructured":"Tabrizi SJ, et al. Potential disease-modifying therapies for Huntington\u2019s disease: lessons learned and future opportunities. Lancet Neurol. 2022;21(7):645\u201358.","journal-title":"Lancet Neurol"},{"issue":"7","key":"3165_CR117","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S1474-4422(22)00120-X","volume":"21","author":"SJ Tabrizi","year":"2022","unstructured":"Tabrizi SJ, et al. A biological classification of Huntington\u2019s disease: the integrated staging system. Lancet Neurol. 2022;21(7):632\u201344.","journal-title":"Lancet Neurol"},{"issue":"2","key":"3165_CR118","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41418-021-00914-9","volume":"29","author":"R Iennaco","year":"2022","unstructured":"Iennaco R, et al. The evolutionary history of the polyQ tract in huntingtin sheds light on its functional pro-neural activities. Cell Death Differ. 2022;29(2):293\u2013305.","journal-title":"Cell Death Differ"},{"key":"3165_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-024-01414-x","author":"R Aviner","year":"2022","unstructured":"Aviner R, et al. Ribotoxic collisions on CAG expansions disrupt proteostasis and stress responses in Huntington\u2019s disease. BiorXiv. 2022. https:\/\/doi.org\/10.1038\/s41556-024-01414-x.","journal-title":"BiorXiv"},{"issue":"6","key":"3165_CR120","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41556-024-01414-x","volume":"26","author":"R Aviner","year":"2024","unstructured":"Aviner R, et al. Polyglutamine-mediated ribotoxicity disrupts proteostasis and stress responses in Huntington\u2019s disease. Nat Cell Biol. 2024;26(6):892\u2013902.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"3165_CR121","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/cge.13857","volume":"99","author":"M Ranganathan","year":"2021","unstructured":"Ranganathan M, et al. Age of onset and behavioral manifestations in Huntington\u2019s disease: an enroll-HD cohort analysis. Clin Genet. 2021;99(1):133\u201342.","journal-title":"Clin Genet"},{"issue":"2","key":"3165_CR122","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3233\/JHD-210475","volume":"11","author":"JH Warner","year":"2022","unstructured":"Warner JH, et al. Standardizing the CAP score in Huntington\u2019s disease by predicting age-at-onset. J Huntingtons Dis. 2022;11(2):153\u201371.","journal-title":"J Huntingtons Dis"},{"issue":"1","key":"3165_CR123","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/JHD-200427","volume":"10","author":"EP Hong","year":"2021","unstructured":"Hong EP, et al. Huntington\u2019s disease pathogenesis: two sequential components. J Huntingtons Dis. 2021;10(1):35\u201351.","journal-title":"J Huntingtons Dis"},{"key":"3165_CR124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.603594","volume":"11","author":"G Du","year":"2021","unstructured":"Du G, et al. Altered gut microbiota related to inflammatory responses in patients with Huntington\u2019s disease. Front Immunol. 2021;11:603594.","journal-title":"Front Immunol"},{"key":"3165_CR125","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1088124","volume":"13","author":"Q Jia","year":"2022","unstructured":"Jia Q, et al. Neuroinflammation in Huntington\u2019s disease: from animal models to clinical therapeutics. Front Immunol. 2022;13:1088124.","journal-title":"Front Immunol"},{"key":"3165_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2023.578243","volume":"385","author":"AS Khaboushan","year":"2023","unstructured":"Khaboushan AS, et al. Circulating levels of inflammatory biomarkers in Huntington\u2019s disease: a systematic review and meta-analysis. J Neuroimmunol. 2023;385:578243.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"3165_CR127","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/acn3.52016","volume":"11","author":"H Bilal","year":"2024","unstructured":"Bilal H, et al. Associations of inflammatory cytokines and cortisol with nonmotor features of Huntington\u2019s disease. Ann Clin Transl Neurol. 2024;11(4):989\u201399.","journal-title":"Ann Clin Transl Neurol"},{"issue":"7","key":"3165_CR128","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0305358","volume":"19","author":"EJ Jambi","year":"2024","unstructured":"Jambi EJ, et al. 6-shogaol against 3-nitropropionic acid-induced Huntington\u2019s disease in rodents: based on molecular docking\/targeting pro-inflammatory cytokines\/NF-\u03baB-BDNF-Nrf2 pathway. PLoS ONE. 2024;19(7):e0305358.","journal-title":"PLoS ONE"},{"issue":"6","key":"3165_CR129","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2174\/1570159X19666211201094608","volume":"20","author":"J Saba","year":"2022","unstructured":"Saba J, et al. Neuroinflammation in Huntington\u2019s disease: a starring role for astrocyte and microglia. Curr Neuropharmacol. 2022;20(6):1116\u201343.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"3165_CR130","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/nyas.14977","volume":"1522","author":"BS Khakh","year":"2023","unstructured":"Khakh BS, Goldman SA. Astrocytic contributions to Huntington\u2019s disease pathophysiology. Ann N Y Acad Sci. 2023;1522(1):42\u201359.","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"3165_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116089","volume":"23","author":"L G\u00f3mez-Jaramillo","year":"2022","unstructured":"G\u00f3mez-Jaramillo L, et al. A new perspective on Huntington\u2019s disease: how a neurological disorder influences the peripheral tissues. Int J Mol Sci. 2022;23(11):6089.","journal-title":"Int J Mol Sci"},{"key":"3165_CR132","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.molimm.2022.09.002","volume":"151","author":"T de Oliveira Furlam","year":"2022","unstructured":"de Oliveira Furlam T, et al. Inflammasome activation and assembly in Huntington\u2019s disease. Mol Immunol. 2022;151:134\u201342.","journal-title":"Mol Immunol"},{"issue":"15","key":"3165_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158363","volume":"23","author":"E Paldino","year":"2022","unstructured":"Paldino E, Fusco FR. Emerging role of NLRP3 inflammasome\/pyroptosis in Huntington\u2019s disease. Int J Mol Sci. 2022;23(15):8363.","journal-title":"Int J Mol Sci"},{"issue":"16 Suppl","key":"3165_CR134","first-page":"s294","volume":"19","author":"CE Markowitz","year":"2013","unstructured":"Markowitz CE. Multiple sclerosis update. Am J Manag Care. 2013;19(16 Suppl):s294-300.","journal-title":"Am J Manag Care"},{"issue":"6","key":"3165_CR135","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nri3452","volume":"13","author":"E Latz","year":"2013","unstructured":"Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol. 2013;13(6):397\u2013411.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3165_CR136","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1600-065X.2011.01044.x","volume":"243","author":"EA Miao","year":"2011","unstructured":"Miao EA, Rajan JV, Aderem A. Caspase-1-induced pyroptotic cell death. Immunol Rev. 2011;243(1):206\u201314.","journal-title":"Immunol Rev"},{"issue":"6","key":"3165_CR137","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805\u201320.","journal-title":"Cell"},{"issue":"50","key":"3165_CR138","doi-asserted-by":"publisher","first-page":"41732","DOI":"10.1074\/jbc.M112.381228","volume":"287","author":"PR Vajjhala","year":"2012","unstructured":"Vajjhala PR, Mirams RE, Hill JM. Multiple binding sites on the pyrin domain of ASC protein allow self-association and interaction with NLRP3 protein. J Biol Chem. 2012;287(50):41732\u201343.","journal-title":"J Biol Chem"},{"issue":"7329","key":"3165_CR139","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou R, et al. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469(7329):221\u20135.","journal-title":"Nature"},{"issue":"5","key":"3165_CR140","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ni.2550","volume":"14","author":"T Misawa","year":"2013","unstructured":"Misawa T, et al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat Immunol. 2013;14(5):454\u201360.","journal-title":"Nat Immunol"},{"issue":"6996","key":"3165_CR141","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nature02664","volume":"430","author":"S Mariathasan","year":"2004","unstructured":"Mariathasan S, et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature. 2004;430(6996):213\u20138.","journal-title":"Nature"},{"key":"3165_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4209","volume":"5","author":"N Van Opdenbosch","year":"2014","unstructured":"Van Opdenbosch N, et al. Activation of the NLRP1b inflammasome independently of ASC-mediated caspase-1 autoproteolysis and speck formation. Nat Commun. 2014;5:3209.","journal-title":"Nat Commun"},{"issue":"2","key":"3165_CR143","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10(2):417\u201326.","journal-title":"Mol Cell"},{"key":"3165_CR144","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","volume":"38","author":"S Kesavardhana","year":"2020","unstructured":"Kesavardhana S, Malireddi RKS, Kanneganti TD. Caspases in cell death, inflammation, and pyroptosis. Annu Rev Immunol. 2020;38:567\u201395.","journal-title":"Annu Rev Immunol"},{"issue":"7575","key":"3165_CR145","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki N, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015;526(7575):666\u201371.","journal-title":"Nature"},{"issue":"3","key":"3165_CR146","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ni.3333","volume":"17","author":"H Shi","year":"2016","unstructured":"Shi H, et al. Nlrp3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat Immunol. 2016;17(3):250\u20138.","journal-title":"Nat Immunol"},{"issue":"28","key":"3165_CR147","doi-asserted-by":"publisher","first-page":"7858","DOI":"10.1073\/pnas.1607769113","volume":"113","author":"RA Aglietti","year":"2016","unstructured":"Aglietti RA, et al. GsmdD p30 elicited by caspase-11 during pyroptosis forms pores in membranes. Proc Natl Acad Sci U S A. 2016;113(28):7858\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"3165_CR148","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.4049\/jimmunol.2000373","volume":"204","author":"S Matikainen","year":"2020","unstructured":"Matikainen S, Nyman TA, Cypryk W. Function and regulation of noncanonical Caspase-4\/5\/11 inflammasome. J Immunol. 2020;204(12):3063\u20139.","journal-title":"J Immunol"},{"issue":"4","key":"3165_CR149","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175336","volume":"12","author":"F Awad","year":"2017","unstructured":"Awad F, et al. Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation. PLoS ONE. 2017;12(4):e0175336.","journal-title":"PLoS ONE"},{"issue":"7434","key":"3165_CR150","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493(7434):674\u20138.","journal-title":"Nature"},{"issue":"2","key":"3165_CR151","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3233\/JAD-181259","volume":"72","author":"F La Rosa","year":"2019","unstructured":"La Rosa F, et al. Stavudine reduces NLRP3 inflammasome activation and modulates amyloid-\u03b2 autophagy. J Alzheimers Dis. 2019;72(2):401\u201312.","journal-title":"J Alzheimers Dis"},{"key":"3165_CR152","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-016-0088-1","volume":"11","author":"M Saresella","year":"2016","unstructured":"Saresella M, et al. The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer\u2019s disease. Mol Neurodegener. 2016;11:23.","journal-title":"Mol Neurodegener"},{"issue":"8","key":"3165_CR153","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle A, et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol. 2008;9(8):857\u201365.","journal-title":"Nat Immunol"},{"issue":"2","key":"3165_CR154","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/bpa.12483","volume":"27","author":"MT Heneka","year":"2017","unstructured":"Heneka MT. Inflammasome activation and innate immunity in Alzheimer\u2019s disease. Brain Pathol. 2017;27(2):220\u20132.","journal-title":"Brain Pathol"},{"key":"3165_CR155","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","volume":"61","author":"C Dempsey","year":"2017","unstructured":"Dempsey C, et al. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice. Brain Behav Immun. 2017;61:306\u201316.","journal-title":"Brain Behav Immun"},{"issue":"12","key":"3165_CR156","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.503","volume":"4","author":"B Parajuli","year":"2013","unstructured":"Parajuli B, et al. Oligomeric amyloid \u03b2 induces IL-1\u03b2 processing via production of ROS: implication in Alzheimer\u2019s disease. Cell Death Dis. 2013;4(12):e975.","journal-title":"Cell Death Dis"},{"issue":"10","key":"3165_CR157","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1038\/cdd.2015.16","volume":"22","author":"V Kaushal","year":"2015","unstructured":"Kaushal V, et al. Neuronal NLRP1 inflammasome activation of caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated caspase-6 activation. Cell Death Differ. 2015;22(10):1676\u201386.","journal-title":"Cell Death Differ"},{"issue":"2","key":"3165_CR158","doi-asserted-by":"publisher","first-page":"974","DOI":"10.4049\/jimmunol.0904145","volume":"185","author":"D Gris","year":"2010","unstructured":"Gris D, et al. Nlrp3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J Immunol. 2010;185(2):974\u201381.","journal-title":"J Immunol"},{"issue":"8","key":"3165_CR159","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/nn.3168","volume":"15","author":"RM Ransohoff","year":"2012","unstructured":"Ransohoff RM. Animal models of multiple sclerosis: the good, the bad and the bottom line. Nat Neurosci. 2012;15(8):1074\u20137.","journal-title":"Nat Neurosci"},{"issue":"2","key":"3165_CR160","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.molimm.2014.10.008","volume":"63","author":"E Peelen","year":"2015","unstructured":"Peelen E, et al. Increased inflammasome related gene expression profile in PBMC may facilitate T helper 17 cell induction in multiple sclerosis. Mol Immunol. 2015;63(2):521\u20139.","journal-title":"Mol Immunol"},{"key":"3165_CR161","volume":"2013","author":"M Inoue","year":"2013","unstructured":"Inoue M, Shinohara ML. NLRP3 Inflammasome and MS\/EAE. Autoimmune Dis. 2013;2013:859145.","journal-title":"Autoimmune Dis"},{"issue":"9","key":"3165_CR162","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1093\/brain\/awx133","volume":"140","author":"MK Mamik","year":"2017","unstructured":"Mamik MK, Power C. Inflammasomes in neurological diseases: emerging pathogenic and therapeutic concepts. Brain. 2017;140(9):2273\u201385.","journal-title":"Brain"},{"issue":"6","key":"3165_CR163","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1136\/jnnp.67.6.785","volume":"67","author":"R Furlan","year":"1999","unstructured":"Furlan R, et al. Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study. J Neurol Neurosurg Psychiatry. 1999;67(6):785\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1\u20132","key":"3165_CR164","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0022-510X(02)00030-8","volume":"197","author":"X Ming","year":"2002","unstructured":"Ming X, et al. Caspase-1 expression in multiple sclerosis plaques and cultured glial cells. J Neurol Sci. 2002;197(1\u20132):9\u201318.","journal-title":"J Neurol Sci"},{"key":"3165_CR165","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00135","volume":"9","author":"RW Keane","year":"2018","unstructured":"Keane RW, Dietrich WD, de Rivero Vaccari JP. Inflammasome proteins as biomarkers of multiple sclerosis. Front Neurol. 2018;9:135.","journal-title":"Front Neurol"},{"issue":"3","key":"3165_CR166","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1034\/j.1600-0404.2001.00356.x","volume":"104","author":"J Losy","year":"2001","unstructured":"Losy J, Niezgoda A. IL-18 in patients with multiple sclerosis. Acta Neurol Scand. 2001;104(3):171\u20133.","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"3165_CR167","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1212\/WNL.57.2.342","volume":"57","author":"F Nicoletti","year":"2001","unstructured":"Nicoletti F, et al. Increased serum levels of interleukin-18 in patients with multiple sclerosis. Neurology. 2001;57(2):342\u20134.","journal-title":"Neurology"},{"issue":"1\u20132","key":"3165_CR168","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jneuroim.2011.12.008","volume":"243","author":"YC Chen","year":"2012","unstructured":"Chen YC, et al. Serum levels of interleukin (IL)-18, IL-23 and IL-17 in Chinese patients with multiple sclerosis. J Neuroimmunol. 2012;243(1\u20132):56\u201360.","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"3165_CR169","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0165-5728(02)00056-5","volume":"126","author":"BA de Jong","year":"2002","unstructured":"de Jong BA, et al. Production of IL-1beta and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis. J Neuroimmunol. 2002;126(1\u20132):172\u20139.","journal-title":"J Neuroimmunol"},{"issue":"11","key":"3165_CR170","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1073\/pnas.0812183106","volume":"106","author":"D Burger","year":"2009","unstructured":"Burger D, et al. Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis. Proc Natl Acad Sci U S A. 2009;106(11):4355\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3165_CR171","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1006\/cyto.1996.0054","volume":"8","author":"F Nicoletti","year":"1996","unstructured":"Nicoletti F, et al. Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment. Cytokine. 1996;8(5):395\u2013400.","journal-title":"Cytokine"},{"issue":"1","key":"3165_CR172","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055375","volume":"8","author":"G Codolo","year":"2013","unstructured":"Codolo G, et al. Triggering of inflammasome by aggregated \u03b1-synuclein, an inflammatory response in synucleinopathies. PLoS ONE. 2013;8(1):e55375.","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"3165_CR173","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","volume":"160","author":"Y Yan","year":"2015","unstructured":"Yan Y, et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell. 2015;160(1\u20132):62\u201373.","journal-title":"Cell"},{"issue":"31","key":"3165_CR174","doi-asserted-by":"publisher","first-page":"13052","DOI":"10.1073\/pnas.0906277106","volume":"106","author":"E Junn","year":"2009","unstructured":"Junn E, et al. Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc Natl Acad Sci U S A. 2009;106(31):13052\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3165_CR175","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-016-0094-3","volume":"11","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, et al. Microrna-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson\u2019s disease. Mol Neurodegener. 2016;11:28.","journal-title":"Mol Neurodegener"},{"issue":"2","key":"3165_CR176","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","volume":"26","author":"E Lee","year":"2019","unstructured":"Lee E, et al. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Cell Death Differ. 2019;26(2):213\u201328.","journal-title":"Cell Death Differ"},{"key":"3165_CR177","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12504","volume":"7","author":"MJ Daniels","year":"2016","unstructured":"Daniels MJ, et al. Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer\u2019s disease in rodent models. Nat Commun. 2016;7:12504.","journal-title":"Nat Commun"},{"issue":"3","key":"3165_CR178","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2174\/156652411795243450","volume":"11","author":"PA McCombe","year":"2011","unstructured":"McCombe PA, Henderson RD. The role of immune and inflammatory mechanisms in ALS. Curr Mol Med. 2011;11(3):246\u201354.","journal-title":"Curr Mol Med"},{"issue":"9","key":"3165_CR179","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1172\/JCI90607","volume":"127","author":"D Lall","year":"2017","unstructured":"Lall D, Baloh RH. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia. J Clin Invest. 2017;127(9):3250\u20138.","journal-title":"J Clin Invest"},{"issue":"29","key":"3165_CR180","doi-asserted-by":"publisher","first-page":"13046","DOI":"10.1073\/pnas.1002396107","volume":"107","author":"F Meissner","year":"2010","unstructured":"Meissner F, Molawi K, Zychlinsky A. Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis. Proc Natl Acad Sci U S A. 2010;107(29):13046\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3165_CR181","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/bpa.12467","volume":"28","author":"B Debye","year":"2018","unstructured":"Debye B, et al. Neurodegeneration and NLRP3 inflammasome expression in the anterior thalamus of SOD1(G93A) ALS mice. Brain Pathol. 2018;28(1):14\u201327.","journal-title":"Brain Pathol"},{"issue":"12","key":"3165_CR182","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1002\/glia.22891","volume":"63","author":"S Johann","year":"2015","unstructured":"Johann S, et al. NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients. Glia. 2015;63(12):2260\u201373.","journal-title":"Glia"},{"issue":"2","key":"3165_CR183","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nri2922","volume":"11","author":"D Mathis","year":"2011","unstructured":"Mathis D, Shoelson SE. Immunometabolism: an emerging frontier. Nat Rev Immunol. 2011;11(2):81.","journal-title":"Nat Rev Immunol"},{"issue":"7121","key":"3165_CR184","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860\u20137.","journal-title":"Nature"},{"issue":"7","key":"3165_CR185","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1172\/JCI29069","volume":"116","author":"SE Shoelson","year":"2006","unstructured":"Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793\u2013801.","journal-title":"J Clin Invest"},{"issue":"2","key":"3165_CR186","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri2921","volume":"11","author":"N Ouchi","year":"2011","unstructured":"Ouchi N, et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85\u201397.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3165_CR187","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1600-065X.2010.00987.x","volume":"240","author":"GA Rook","year":"2011","unstructured":"Rook GA, Dalgleish A. Infection, immunoregulation, and cancer. Immunol Rev. 2011;240(1):141\u201359.","journal-title":"Immunol Rev"},{"issue":"10","key":"3165_CR188","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s11064-007-9385-y","volume":"32","author":"BE Leonard","year":"2007","unstructured":"Leonard BE. Inflammation, depression and dementia: are they connected? Neurochem Res. 2007;32(10):1749\u201356.","journal-title":"Neurochem Res"},{"issue":"3","key":"3165_CR189","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/jama.286.3.327","volume":"286","author":"AD Pradhan","year":"2001","unstructured":"Pradhan AD, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286(3):327\u201334.","journal-title":"JAMA"},{"key":"3165_CR190","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1600-0838.2006.00520.x","volume":"16","author":"BK Pedersen","year":"2006","unstructured":"Pedersen BK, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports. 2006;16:3\u201363.","journal-title":"Scand J Med Sci Sports"},{"key":"3165_CR191","doi-asserted-by":"publisher","DOI":"10.4324\/9780203890714","volume-title":"Physical activity and health: the evidence explained","author":"AE Hardman","year":"2009","unstructured":"Hardman AE, Stensel DJ. Physical activity and health: the evidence explained. London: Routledge; 2009."},{"issue":"5","key":"3165_CR192","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1249\/MSS.0b013e3181c3aa7e","volume":"42","author":"TY Warren","year":"2010","unstructured":"Warren TY, et al. Sedentary behaviors increase risk of cardiovascular disease mortality in men. Med Sci Sports Exerc. 2010;42(5):879\u201385.","journal-title":"Med Sci Sports Exerc"},{"key":"3165_CR193","first-page":"6","volume":"17","author":"NP Walsh","year":"2011","unstructured":"Walsh NP, et al. Position statement. Part one: immune function and exercise. Exerc Immunol Rev. 2011;17:6\u201363.","journal-title":"Exerc Immunol Rev"},{"key":"3165_CR194","volume-title":"ACSM's exercise is medicine TM: a clinician's guide to exercise prescription","author":"S Jonas","year":"2012","unstructured":"Jonas S, Phillips EM. ACSM\u2019s exercise is medicine TM: a clinician\u2019s guide to exercise prescription. Ambler: Lippincott Williams & Wilkins; 2012."},{"issue":"19","key":"3165_CR195","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1056\/NEJMoa020194","volume":"347","author":"WE Kraus","year":"2002","unstructured":"Kraus WE, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med. 2002;347(19):1483\u201392.","journal-title":"N Engl J Med"},{"issue":"10","key":"3165_CR196","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.jacc.2004.12.077","volume":"45","author":"C Kasapis","year":"2005","unstructured":"Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol. 2005;45(10):1563\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"3165_CR197","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/109502","volume":"2008","author":"N Mathur","year":"2008","unstructured":"Mathur N, Pedersen BK. Exercise as a mean to control low-grade systemic inflammation. Mediat Inflamm. 2008;2008:109502.","journal-title":"Mediat Inflamm"},{"issue":"4","key":"3165_CR198","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1249\/01.jes.0000240027.22749.14","volume":"34","author":"MG Flynn","year":"2006","unstructured":"Flynn MG, McFarlin BK. Toll-like receptor 4: link to the anti-inflammatory effects of exercise? Exerc Sport Sci Rev. 2006;34(4):176\u201381.","journal-title":"Exerc Sport Sci Rev"},{"issue":"4","key":"3165_CR199","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1152\/physrev.90100.2007","volume":"88","author":"BK Pedersen","year":"2008","unstructured":"Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev. 2008;88(4):1379\u2013406.","journal-title":"Physiol Rev"},{"key":"3165_CR200","first-page":"34","volume":"12","author":"M Gleeson","year":"2006","unstructured":"Gleeson M, McFarlin B, Flynn M. Exercise and toll-like receptors. Exerc Immunol Rev. 2006;12:34\u201353.","journal-title":"Exerc Immunol Rev"},{"key":"3165_CR201","first-page":"105","volume":"16","author":"N Kawanishi","year":"2010","unstructured":"Kawanishi N, et al. Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice. Exerc Immunol Rev. 2010;16:105\u201318.","journal-title":"Exerc Immunol Rev"},{"issue":"5","key":"3165_CR202","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1189\/jlb.0408244","volume":"84","author":"KL Timmerman","year":"2008","unstructured":"Timmerman KL, et al. Exercise training-induced lowering of inflammatory (CD14+CD16+) monocytes: a role in the anti-inflammatory influence of exercise? J Leukoc Biol. 2008;84(5):1271\u20138.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"3165_CR203","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1136\/bjsm.2005.022095","volume":"40","author":"SH Yeh","year":"2006","unstructured":"Yeh SH, et al. Regular tai chi chuan exercise enhances functional mobility and CD4CD25 regulatory T cells. Br J Sports Med. 2006;40(3):239\u201343.","journal-title":"Br J Sports Med"},{"issue":"5","key":"3165_CR204","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1600-0838.2010.01288.x","volume":"22","author":"J Wang","year":"2012","unstructured":"Wang J, et al. Effect of exercise training intensity on murine T-regulatory cells and vaccination response. Scand J Med Sci Sports. 2012;22(5):643\u201352.","journal-title":"Scand J Med Sci Sports"},{"issue":"2","key":"3165_CR205","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.2279","volume":"17","author":"B Vandanmagsar","year":"2011","unstructured":"Vandanmagsar B, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17(2):179\u201388.","journal-title":"Nat Med"},{"key":"3165_CR206","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21114184","author":"KK Wu","year":"2020","unstructured":"Wu KK, Cheung SW, Cheng KK. NLRP3 inflammasome activation in adipose tissues and its implications on metabolic diseases. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21114184.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"3165_CR207","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s12272-020-01295-2","volume":"43","author":"DL ZhuGe","year":"2020","unstructured":"ZhuGe DL, et al. Fibroblast growth factor 2 exacerbates inflammation in adipocytes through NLRP3 inflammasome activation. Arch Pharm Res. 2020;43(12):1311\u201324.","journal-title":"Arch Pharm Res"},{"issue":"12","key":"3165_CR208","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1172\/JCI90699","volume":"127","author":"MD McGeough","year":"2017","unstructured":"McGeough MD, et al. TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies. J Clin Invest. 2017;127(12):4488\u201397.","journal-title":"J Clin Invest"},{"issue":"7","key":"3165_CR209","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.4049\/jimmunol.1501336","volume":"197","author":"F Bauernfeind","year":"2016","unstructured":"Bauernfeind F, et al. Aging-associated TNF production primes inflammasome activation and NLRP3-related metabolic disturbances. J Immunol. 2016;197(7):2900\u20138.","journal-title":"J Immunol"},{"issue":"3","key":"3165_CR210","first-page":"98","volume":"41","author":"XI Shuyu","year":"2015","unstructured":"Shuyu XI. Effect of treadmill exercise of different intensity on the ppar\u03b3\/adiponectin\/TNF-\u03b1 mRNA in adipose tissue of rats fed with high fat diet. J Chengdu Sport Univ. 2015;41(3):98\u2013102.","journal-title":"J Chengdu Sport Univ"},{"issue":"5","key":"3165_CR211","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nm.3159","volume":"19","author":"M Ahmadian","year":"2013","unstructured":"Ahmadian M, et al. PPAR\u03b3 signaling and metabolism: the good, the bad and the future. Nat Med. 2013;19(5):557\u201366.","journal-title":"Nat Med"},{"key":"3165_CR212","doi-asserted-by":"publisher","first-page":"4536470","DOI":"10.1155\/2016\/4536470","volume":"2016","author":"C Mardare","year":"2016","unstructured":"Mardare C, et al. Endurance and resistance training affect high fat diet-induced increase of ceramides, inflammasome expression, and systemic inflammation in mice. J Diabetes Res. 2016;2016:4536470.","journal-title":"J Diabetes Res"},{"issue":"1","key":"3165_CR213","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41420-021-00434-y","volume":"7","author":"R Yue","year":"2021","unstructured":"Yue R, et al. NLRP3-mediated pyroptosis aggravates pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction in mice: cardioprotective role of irisin. Cell Death Discov. 2021;7(1):50.","journal-title":"Cell Death Discov"},{"key":"3165_CR214","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-981-15-1792-1_3","volume":"1228","author":"Z Gholamnezhad","year":"2020","unstructured":"Gholamnezhad Z, M\u00e9garbane B, Rezaee R. Molecular mechanisms mediating adaptation to exercise. Adv Exp Med Biol. 2020;1228:45\u201361.","journal-title":"Adv Exp Med Biol"},{"key":"3165_CR215","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.12343","author":"JS Lally","year":"2015","unstructured":"Lally JS, et al. Skeletal muscle AMPK is essential for the maintenance of FNDC5 expression. Physiol Rep. 2015. https:\/\/doi.org\/10.14814\/phy2.12343.","journal-title":"Physiol Rep"},{"key":"3165_CR216","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.molimm.2017.09.014","volume":"91","author":"J Peng","year":"2017","unstructured":"Peng J, et al. Irisin protects against neuronal injury induced by oxygen-glucose deprivation in part depends on the inhibition of ROS-NLRP3 inflammatory signaling pathway. Mol Immunol. 2017;91:185\u201394.","journal-title":"Mol Immunol"},{"issue":"6","key":"3165_CR217","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/14737175.2019.1618710","volume":"19","author":"IA Clark","year":"2019","unstructured":"Clark IA, Vissel B. Neurodegenerative disease treatments by direct TNF reduction, SB623 cells, maraviroc and irisin and MCC950, from an inflammatory perspective\u2014a commentary. Expert Rev Neurother. 2019;19(6):535\u201343.","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"3165_CR218","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000437173","volume":"67","author":"G Sanchez-Delgado","year":"2015","unstructured":"Sanchez-Delgado G, et al. Role of exercise in the activation of brown adipose tissue. Ann Nutr Metab. 2015;67(1):21\u201332.","journal-title":"Ann Nutr Metab"},{"key":"3165_CR219","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.vph.2015.05.008","volume":"74","author":"P Abeyrathna","year":"2015","unstructured":"Abeyrathna P, Su Y. The critical role of Akt in cardiovascular function. Vascul Pharmacol. 2015;74:38\u201348.","journal-title":"Vascul Pharmacol"},{"issue":"1","key":"3165_CR220","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13287-017-0668-1","volume":"8","author":"X Sun","year":"2017","unstructured":"Sun X, et al. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats. Stem Cell Res Ther. 2017;8(1):241.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3165_CR221","first-page":"12","volume":"36","author":"XJ Yi","year":"2020","unstructured":"Yi XJ, et al. Effects of acute and chronic exercise on fat PI3K\/AKT\/GLUT4 signal pathway in type 2 diabetic rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2020;36(1):12\u20136.","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"issue":"7","key":"3165_CR222","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70061","volume":"24","author":"R Zhao","year":"2025","unstructured":"Zhao R, et al. Aerobic exercise restores hippocampal neurogenesis and cognitive function by decreasing microglia inflammasome formation through Irisin\/NLRP3 pathway. Aging Cell. 2025;24(7):e70061.","journal-title":"Aging Cell"},{"key":"3165_CR223","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.brainresbull.2021.06.024","volume":"174","author":"W Wang","year":"2021","unstructured":"Wang W, et al. Treadmill exercise alleviates neuronal damage by suppressing NLRP3 inflammasome and microglial activation in the MPTP mouse model of Parkinson\u2019s disease. Brain Res Bull. 2021;174:349\u201358.","journal-title":"Brain Res Bull"},{"key":"3165_CR224","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113952","volume":"349","author":"M-X Liu","year":"2022","unstructured":"Liu M-X, et al. Exercise-induced neuroprotection against cerebral ischemia\/reperfusion injury is mediated via alleviating inflammasome-induced pyroptosis. Exp Neurol. 2022;349:113952.","journal-title":"Exp Neurol"},{"key":"3165_CR225","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070691","author":"O Mee-Inta","year":"2019","unstructured":"Mee-Inta O, Zhao ZW, Kuo YM. Physical exercise inhibits inflammation and microglial activation. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8070691.","journal-title":"Cells"},{"issue":"7","key":"3165_CR226","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1007\/s40520-021-02069-6","volume":"34","author":"C Ma","year":"2022","unstructured":"Ma C, et al. The impact of physical activity on blood inflammatory cytokines and neuroprotective factors in individuals with mild cognitive impairment: a systematic review and meta-analysis of randomized-controlled trials. Aging Clin Exp Res. 2022;34(7):1471\u201384.","journal-title":"Aging Clin Exp Res"},{"key":"3165_CR227","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2022.107018","volume":"186","author":"G de Lima Rosa","year":"2022","unstructured":"de Lima Rosa G, et al. Aerobic exercise, alone or combined with an anti-inflammatory drug, reduces the severity of epileptic seizures and levels of central pro-inflammatory cytokines in an animal model of epileptic seizures. Epilepsy Res. 2022;186:107018.","journal-title":"Epilepsy Res"},{"issue":"1","key":"3165_CR228","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s11033-025-10248-1","volume":"52","author":"MO Oyovwi","year":"2025","unstructured":"Oyovwi MO, Ogenma UT, Onyenweny A. Exploring the impact of exercise-induced BDNF on neuroplasticity in neurodegenerative and neuropsychiatric conditions. Mol Biol Rep. 2025;52(1):140.","journal-title":"Mol Biol Rep"},{"issue":"11","key":"3165_CR229","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3390\/brainsci11111499","volume":"11","author":"MD Diechmann","year":"2021","unstructured":"Diechmann MD, et al. Effects of exercise training on neurotrophic factors and subsequent neuroprotection in persons with multiple sclerosis\u2014a systematic review and meta-analysis. Brain Sci. 2021;11(11):1499.","journal-title":"Brain Sci"},{"issue":"2","key":"3165_CR230","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11011-020-00646-8","volume":"36","author":"JM Rosa","year":"2021","unstructured":"Rosa JM, et al. Physical exercise prevents amyloid \u03b2(1\u201340)-induced disturbances in NLRP3 inflammasome pathway in the hippocampus of mice. Metab Brain Dis. 2021;36(2):351\u20139.","journal-title":"Metab Brain Dis"},{"issue":"4","key":"3165_CR231","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.smhs.2023.09.009","volume":"5","author":"X Li","year":"2023","unstructured":"Li X, et al. Long-term exercise training inhibits inflammation by suppressing hippocampal NLRP3 in APP\/PS1 mice. Sports Med Health Sci. 2023;5(4):329\u201335.","journal-title":"Sports Med Health Sci"},{"issue":"9","key":"3165_CR232","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s40520-022-02153-5","volume":"34","author":"P Malczynska-Sims","year":"2022","unstructured":"Malczynska-Sims P, et al. High-intensity interval training modulates inflammatory response in Parkinson\u2019s disease. Aging Clin Exp Res. 2022;34(9):2165\u201376.","journal-title":"Aging Clin Exp Res"},{"key":"3165_CR233","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.brainres.2016.10.029","volume":"1655","author":"Y Jang","year":"2017","unstructured":"Jang Y, et al. Neuroprotective effects of endurance exercise against neuroinflammation in MPTP-induced Parkinson\u2019s disease mice. Brain Res. 2017;1655:186\u201393.","journal-title":"Brain Res"},{"issue":"9","key":"3165_CR234","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0960-8966(03)00104-4","volume":"13","author":"JH Veldink","year":"2003","unstructured":"Veldink JH, et al. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord. 2003;13(9):737\u201343.","journal-title":"Neuromuscul Disord"},{"issue":"11","key":"3165_CR235","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1111\/j.1460-9568.2004.03769.x","volume":"20","author":"D Liebetanz","year":"2004","unstructured":"Liebetanz D, et al. Extensive exercise is not harmful in amyotrophic lateral sclerosis. Eur J Neurosci. 2004;20(11):3115\u201320.","journal-title":"Eur J Neurosci"},{"issue":"Pt 14","key":"3165_CR236","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1113\/jphysiol.2009.169748","volume":"587","author":"S Deforges","year":"2009","unstructured":"Deforges S, et al. Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. J Physiol. 2009;587(Pt 14):3561\u201372.","journal-title":"J Physiol"},{"key":"3165_CR237","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.neuroscience.2017.01.016","volume":"346","author":"TW Kim","year":"2017","unstructured":"Kim TW, Sung YH. Regular exercise promotes memory function and enhances hippocampal neuroplasticity in experimental autoimmune encephalomyelitis mice. Neuroscience. 2017;346:173\u201381.","journal-title":"Neuroscience"},{"issue":"2","key":"3165_CR238","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s12020-017-1337-y","volume":"57","author":"M Mokhtarzade","year":"2017","unstructured":"Mokhtarzade M, et al. Effect of aerobic interval training on serum IL-10, TNF\u03b1, and adipokines levels in women with multiple sclerosis: possible relations with fatigue and quality of life. Endocrine. 2017;57(2):262\u201371.","journal-title":"Endocrine"},{"issue":"7806","key":"3165_CR239","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581(7806):71\u20136.","journal-title":"Nature"},{"issue":"2","key":"3165_CR240","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/JLB.3CE0122-019R","volume":"112","author":"AW Kerr","year":"2022","unstructured":"Kerr AW, et al. T-cell activation and LPS: a dangerous duo for organ dysfunction. J Leukoc Biol. 2022;112(2):219\u201320.","journal-title":"J Leukoc Biol"},{"issue":"10","key":"3165_CR241","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165823","volume":"1866","author":"DDL Scheffer","year":"2020","unstructured":"Scheffer DDL, Latini A. Exercise-induced immune system response: anti-inflammatory status on peripheral and central organs. Biochim Biophys Acta Mol Basis Dis. 2020;1866(10):165823.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3165_CR242","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121440","volume":"321","author":"PC Da Rosa","year":"2023","unstructured":"Da Rosa PC, et al. The physical exercise-induced oxidative\/inflammatory response in peripheral blood mononuclear cells: Signaling cellular energetic stress situations. Life Sci. 2023;321:121440.","journal-title":"Life Sci"},{"key":"3165_CR243","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2023.107240","volume":"131","author":"NP Gothe","year":"2023","unstructured":"Gothe NP, et al. Yoga, aerobic and stretching exercise effects on neurocognition: Randomized controlled trial protocol. Contemp Clin Trials. 2023;131:107240.","journal-title":"Contemp Clin Trials"},{"key":"3165_CR244","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.967683","volume":"13","author":"K Chen","year":"2022","unstructured":"Chen K, Wang K, Wang T. Protective effect of irisin against Alzheimer\u2019s disease. Front Psychiatry. 2022;13:967683.","journal-title":"Front Psychiatry"},{"key":"3165_CR245","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103101","volume":"71","author":"JW Choi","year":"2024","unstructured":"Choi JW, et al. Aerobic exercise attenuates LPS-induced cognitive dysfunction by reducing oxidative stress, glial activation, and neuroinflammation. Redox Biol. 2024;71:103101.","journal-title":"Redox Biol"},{"issue":"5","key":"3165_CR246","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jshs.2020.04.001","volume":"9","author":"SK Powers","year":"2020","unstructured":"Powers SK, et al. Exercise-induced oxidative stress: friend or foe? J Sport Health Sci. 2020;9(5):415\u201325.","journal-title":"J Sport Health Sci"},{"issue":"1","key":"3165_CR247","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.immuni.2020.11.005","volume":"54","author":"DA Mogilenko","year":"2021","unstructured":"Mogilenko DA, et al. Comprehensive profiling of an aging immune system reveals clonal GZMK(+) CD8(+) T cells as conserved hallmark of inflammaging. Immunity. 2021;54(1):99-115.e12.","journal-title":"Immunity"},{"issue":"23\u201324","key":"3165_CR248","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1101\/gad.343129.120","volume":"34","author":"J Birch","year":"2020","unstructured":"Birch J, Gil J. Senescence and the SASP: many therapeutic avenues. Genes Dev. 2020;34(23\u201324):1565\u201376.","journal-title":"Genes Dev"},{"issue":"7983","key":"3165_CR249","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41586-023-06621-4","volume":"622","author":"S Victorelli","year":"2023","unstructured":"Victorelli S, et al. Apoptotic stress causes mtDNA release during senescence and drives the SASP. Nature. 2023;622(7983):627\u201336.","journal-title":"Nature"},{"key":"3165_CR250","doi-asserted-by":"publisher","first-page":"1444716","DOI":"10.3389\/fnagi.2024.1444716","volume":"16","author":"J Hu","year":"2024","unstructured":"Hu J, Huang B, Chen K. The impact of physical exercise on neuroinflammation mechanism in Alzheimer\u2019s disease. Front Aging Neurosci. 2024;16:1444716.","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"3165_CR251","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/physiologia5020013","volume":"5","author":"M Mansoor","year":"2025","unstructured":"Mansoor M, et al. Exercise-induced neuroplasticity: adaptive mechanisms and preventive potential in neurodegenerative disorders. Physiologia. 2025;5(2):13.","journal-title":"Physiologia"},{"issue":"7","key":"3165_CR252","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1038\/s41380-024-02464-1","volume":"29","author":"L Liu","year":"2024","unstructured":"Liu L, et al. Running exercise alleviates hippocampal neuroinflammation and shifts the balance of microglial M1\/M2 polarization through adiponectin\/AdipoR1 pathway activation in mice exposed to chronic unpredictable stress. Mol Psychiatry. 2024;29(7):2031\u201342.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"3165_CR253","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41398-019-0662-8","volume":"9","author":"Y Luo","year":"2019","unstructured":"Luo Y, et al. Running exercise protects oligodendrocytes in the medial prefrontal cortex in chronic unpredictable stress rat model. Transl Psychiatry. 2019;9(1):322.","journal-title":"Transl Psychiatry"},{"issue":"Suppl 2","key":"3165_CR254","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.5213\/inj.2142340.170","volume":"25","author":"JM Lee","year":"2021","unstructured":"Lee JM, et al. Preischemic treadmill exercise ameliorates memory impairment and microvasculature damage in rat model of chronic cerebral hypoperfusion. Int Neurourol J. 2021;25(Suppl 2):S72-80.","journal-title":"Int Neurourol J"},{"issue":"10","key":"3165_CR255","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165877","volume":"1866","author":"LFF Royes","year":"2020","unstructured":"Royes LFF. Cross-talk between gut and brain elicited by physical exercise. Biochim Biophys Acta Mol Basis Dis. 2020;1866(10):165877.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3165_CR256","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3389\/fneur.2019.01143","volume":"10","author":"E Palasz","year":"2019","unstructured":"Palasz E, et al. Exercise-induced neuroprotection and recovery of motor function in animal models of Parkinson\u2019s disease. Front Neurol. 2019;10:1143.","journal-title":"Front Neurol"},{"key":"3165_CR257","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.752531","volume":"8","author":"AG Taylor","year":"2021","unstructured":"Taylor AG, et al. High intensity interval training leads to similar inflammatory activation as seen with traditional training in chronic heart failure. Front Cardiovasc Med. 2021;8:752531.","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"3165_CR258","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s40520-022-02153-5","volume":"34","author":"P Malczynska-Sims","year":"2022","unstructured":"Malczynska-Sims P, et al. High-intensity interval training modulates inflammatory response in Parkinson\u2019s disease. Aging Clin Exp Res. 2022;34(9):2165\u201376.","journal-title":"Aging Clin Exp Res"},{"issue":"9","key":"3165_CR259","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s40520-019-01353-w","volume":"32","author":"A O'Callaghan","year":"2020","unstructured":"O\u2019Callaghan A, et al. Comparing the influence of exercise intensity on brain-derived neurotrophic factor serum levels in people with Parkinson\u2019s disease: a pilot study. Aging Clin Exp Res. 2020;32(9):1731\u20138.","journal-title":"Aging Clin Exp Res"},{"issue":"4","key":"3165_CR260","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2340\/16501977-1931","volume":"47","author":"J Marusiak","year":"2015","unstructured":"Marusiak J, et al. Interval training-induced alleviation of rigidity and hypertonia in patients with Parkinson\u2019s disease is accompanied by increased basal serum brain-derived neurotrophic factor. J Rehabil Med. 2015;47(4):372\u20135.","journal-title":"J Rehabil Med"},{"issue":"3","key":"3165_CR261","first-page":"441","volume":"65","author":"JA Zoladz","year":"2014","unstructured":"Zoladz JA, et al. Moderate-intensity interval training increases serum brain-derived neurotrophic factor level and decreases inflammation in Parkinson\u2019s disease patients. J Physiol Pharmacol. 2014;65(3):441\u20138.","journal-title":"J Physiol Pharmacol"},{"issue":"5","key":"3165_CR262","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1177\/15459683231172752","volume":"37","author":"JA Li","year":"2023","unstructured":"Li JA, et al. Does exercise attenuate disease progression in people with Parkinson\u2019s disease? A systematic review with meta-analyses. Neurorehabil Neural Repair. 2023;37(5):328\u201352.","journal-title":"Neurorehabil Neural Repair"},{"key":"3165_CR263","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105725","volume":"171","author":"A Novati","year":"2022","unstructured":"Novati A, Nguyen HP, Schulze-Hentrich J. Environmental stimulation in Huntington disease patients and animal models. Neurobiol Dis. 2022;171:105725.","journal-title":"Neurobiol Dis"},{"key":"3165_CR264","doi-asserted-by":"publisher","DOI":"10.3390\/jfmk7020040","author":"B Trovato","year":"2022","unstructured":"Trovato B, et al. Effects of exercise on skeletal muscle pathophysiology in Huntington\u2019s disease. J Funct Morphol Kinesiol. 2022. https:\/\/doi.org\/10.3390\/jfmk7020040.","journal-title":"J Funct Morphol Kinesiol"},{"key":"3165_CR265","doi-asserted-by":"publisher","DOI":"10.1371\/currents.RRN1281","author":"T Renoir","year":"2011","unstructured":"Renoir T, et al. Effect of enhanced voluntary physical exercise on brain levels of monoamines in Huntington disease mice. PLoS Curr. 2011. https:\/\/doi.org\/10.1371\/currents.RRN1281.","journal-title":"PLoS Curr"},{"issue":"4","key":"3165_CR266","doi-asserted-by":"publisher","first-page":"384","DOI":"10.2174\/1570159X22666240530105516","volume":"23","author":"KF Azman","year":"2025","unstructured":"Azman KF, Zakaria R. Brain-derived neurotrophic factor (BDNF) in Huntington\u2019s disease: neurobiology and therapeutic potential. Curr Neuropharmacol. 2025;23(4):384\u2013403.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"3165_CR267","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1600-0404.1996.tb00038.x","volume":"94","author":"D Strickland","year":"1996","unstructured":"Strickland D, et al. Physical activity, trauma, and ALS: a case-control study. Acta Neurol Scand. 1996;94(1):45\u201350.","journal-title":"Acta Neurol Scand"},{"issue":"7\u20138","key":"3165_CR268","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3109\/21678421.2014.932383","volume":"15","author":"M Gotkine","year":"2014","unstructured":"Gotkine M, Friedlander Y, Hochner H. Triathletes are over-represented in a population of patients with ALS. Amyotroph Later Scler Frontotemporal Degener. 2014;15(7\u20138):534\u20136.","journal-title":"Amyotroph Later Scler Frontotemporal Degener"},{"issue":"Pt 3","key":"3165_CR269","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/brain\/awh373","volume":"128","author":"A Chi\u00f2","year":"2005","unstructured":"Chi\u00f2 A, et al. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain. 2005;128(Pt 3):472\u20136.","journal-title":"Brain"},{"issue":"19","key":"3165_CR270","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1212\/WNL.0b013e31826daf50","volume":"79","author":"EJ Lehman","year":"2012","unstructured":"Lehman EJ, et al. Neurodegenerative causes of death among retired National Football League players. Neurology. 2012;79(19):1970\u20134.","journal-title":"Neurology"},{"issue":"5","key":"3165_CR271","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/mus.20004","volume":"29","author":"DJ Mahoney","year":"2004","unstructured":"Mahoney DJ, et al. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve. 2004;29(5):656\u201362.","journal-title":"Muscle Nerve"},{"key":"3165_CR272","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jneuroim.2018.12.005","volume":"328","author":"Y Xie","year":"2019","unstructured":"Xie Y, et al. Effects of moderate- versus high- intensity swimming training on inflammatory and CD4(+) T cell subset profiles in experimental autoimmune encephalomyelitis mice. J Neuroimmunol. 2019;328:60\u20137.","journal-title":"J Neuroimmunol"},{"key":"3165_CR273","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.msard.2018.06.008","volume":"24","author":"R Negaresh","year":"2018","unstructured":"Negaresh R, et al. Effects of exercise training on cytokines and adipokines in multiple sclerosis: a systematic review. Mult Scler Relat Disord. 2018;24:91\u2013100.","journal-title":"Mult Scler Relat Disord"},{"key":"3165_CR274","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/bs.pmbts.2015.08.001","volume":"135","author":"RJ Simpson","year":"2015","unstructured":"Simpson RJ, et al. Exercise and the regulation of immune functions. Prog Mol Biol Transl Sci. 2015;135:355\u201380.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"1","key":"3165_CR275","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.autrev.2017.11.010","volume":"17","author":"K Sharif","year":"2018","unstructured":"Sharif K, et al. Physical activity and autoimmune diseases: get moving and manage the disease. Autoimmun Rev. 2018;17(1):53\u201372.","journal-title":"Autoimmun Rev"}],"updated-by":[{"DOI":"10.1186\/s40001-026-04612-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000}}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03165-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03165-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03165-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T07:02:27Z","timestamp":1780815747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03165-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":275,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3165"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03165-3","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: \" figs 6 and 7 are revised","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s40001-026-04612-5","URL":"https:\/\/doi.org\/10.1186\/s40001-026-04612-5","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"909"}}